<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34484496</PMID><DateRevised><Year>2021</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1712-9532</ISSN><JournalIssue CitedMedium="Print"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>The Canadian journal of infectious diseases &amp; medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale</Title><ISOAbbreviation>Can J Infect Dis Med Microbiol</ISOAbbreviation></Journal><ArticleTitle>Analysis of the Complete Genomes of Enterovirus 71 Subtypes in China.</ArticleTitle><Pagination><StartPage>5564099</StartPage><MedlinePgn>5564099</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5564099</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/5564099</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) is one of the most pathogens to hand, foot, and mouth disease (HFMD) as well as neurological complications in young children. Molecular characteristic of EV-A71 is important to prevent the virus outbreak. Here, the complete genomes of EV-A71 from China between 1998 and 2019 were downloaded from GenBank. The phylogenetic trees were developed by MEGA7.0 software, and the complete genetic epidemiological characteristics and amino acid mutations of EV-A71 from China were also analysed. The results showed that major epidemic EV-A71 subtype was C4b before 2004, while it turned to C4a after 2004 in mainland China, and C4 and B5 were major subtypes in Taiwan. VP1, VP4, 2C, 3C, 3D, and complete genome sequence can be used for virus genotyping, and VP1, VP4, and complete genomes have obvious advantages over other segments. There were many significant mutations in the viral complete genome sequence. This study indicated that the major C4 and B5 subtypes will contribute to the development of vaccines and drugs of EV-A71 for prevention and monitoring of EV-A71-associated HFMD in China.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Lei Wang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8172-2395</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The 903 RD Hospital of PLA, 14 Lingyin Road, Hangzhou 310017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yuzhu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6963-8676</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The 903 RD Hospital of PLA, 14 Lingyin Road, Hangzhou 310017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8738-8818</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The 903 RD Hospital of PLA, 14 Lingyin Road, Hangzhou 310017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Changgui</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8695-4467</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The 903 RD Hospital of PLA, 14 Lingyin Road, Hangzhou 310017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3864-8446</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou 310003, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Laboratory Medicine, Zhejiang University, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3840-1486</Identifier><AffiliationInfo><Affiliation>Department of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>Can J Infect Dis Med Microbiol</MedlineTA><NlmUniqueID>101226876</NlmUniqueID><ISSNLinking>1712-9532</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>6</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34484496</ArticleId><ArticleId IdType="pmc">PMC8416384</ArticleId><ArticleId IdType="doi">10.1155/2021/5564099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu J., Yang M., Zhao Z, et al. Meteorological factors and the transmissibility of hand, foot, and mouth disease in Xiamen city, China. Frontiers of Medicine. 2020;7 doi: 10.3389/fmed.2020.597375.597375</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.597375</ArticleId><ArticleId IdType="pmc">PMC7862718</ArticleId><ArticleId IdType="pubmed">33553200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lulla V., Dinan A. M., Hosmillo M., et al. An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells. Nature Microbiology. 2019;4(2):280&#x2013;292. doi: 10.1038/s41564-018-0297-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0297-1</ArticleId><ArticleId IdType="pmc">PMC6443042</ArticleId><ArticleId IdType="pubmed">30478287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Lau E. H. Y., Wu P., Cowling B. J. Transmission of hand, foot and mouth disease and its potential driving factors in Hong Kong. Scientific Reports. 2016;6(1) doi: 10.1038/srep27500.27500</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27500</ArticleId><ArticleId IdType="pmc">PMC4895171</ArticleId><ArticleId IdType="pubmed">27271966</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P., Thao N. T. T., Perera D., et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerging Infectious Diseases. 2007;13(11):1733&#x2013;1741. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.-L., Chio C.-P., Su H.-J., et al. The association between enterovirus 71 infections and meteorological parameters in Taiwan. PLoS One. 2012;7(10) doi: 10.1371/journal.pone.0046845.e46845</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046845</ArticleId><ArticleId IdType="pmc">PMC3465260</ArticleId><ArticleId IdType="pubmed">23071650</ArticleId></ArticleIdList></Reference><Reference><Citation>NikNadia N., Sam I.-C., Rampal S., et al. Cyclical patterns of hand, foot and mouth disease caused by enterovirus A71 in Malaysia. PLoS Neglected Tropical Diseases. 2016;10(3) doi: 10.1371/journal.pntd.0004562.e0004562</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004562</ArticleId><ArticleId IdType="pmc">PMC4806993</ArticleId><ArticleId IdType="pubmed">27010319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.-R., Hsu K.-H., et al. An epidemic of enterovirus 71 infection in Taiwan. New England Journal of Medicine. 1999;341(13):929&#x2013;935. doi: 10.1056/nejm199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H., Shimizu Y., Takeuchi Y., Ishiko H., Takada H. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatric Neurology. 1999;20(1):17&#x2013;23. doi: 10.1016/s0887-8994(98)00087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0887-8994(98)00087-3</ArticleId><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Zhu S., Guo X, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virology Journal. 2010;7(1):300&#x2013;306. doi: 10.1186/1743-422X-7-300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-300</ArticleId><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Liu F., Liao Q., et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-71 vaccine. Euro Surveillance. 2017;22(50) doi: 10.2807/1560-7917.es.2017.22.50.16-00824.16-00824</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.es.2017.22.50.16-00824</ArticleId><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong C. Y., Chan K. P., Shah V. A, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatrica. 2003;92(10):1163&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14632332</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. The Lancet Infectious Diseases. 2014;14(4):308&#x2013;318. doi: 10.1016/s1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Li Y., Yang Y., et al. Virological investigation of genetic variation of enterovirus type 71 in hand, foot and mouth disease. Experimental and Therapeutic Medicine. 2020;20(1):543&#x2013;549. doi: 10.3892/etm.2020.8728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8728</ArticleId><ArticleId IdType="pmc">PMC7281934</ArticleId><ArticleId IdType="pubmed">32537012</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P., Liu C.-C., Chow Y.-H., Chou A.-H., Klein M. Review of enterovirus 71 vaccines. Clinical Infectious Diseases. 2015;60(5):797&#x2013;803. doi: 10.1093/cid/ciu852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu852</ArticleId><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>Muslin C., Kain A., Bessaud M., Blondel B., Delpeyroux F. Recombination in enteroviruses, a multi-step modular evolutionary process. Viruses. 2019;11(9):p. 859. doi: 10.3390/v11090859.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090859</ArticleId><ArticleId IdType="pmc">PMC6784155</ArticleId><ArticleId IdType="pubmed">31540135</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B. A., Pallansch M. A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Research. 1996;39(2-3):195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L. C., Chen S. O., Chang S. P., Lee Y. P., Lin C. F. Enterovirus 71 proteins 2A and 3D antagonize the antiviral activity of IFN-&#x3b3; via signaling attenuation. Journal of Virology. 2015;89(14):205&#x2013;215. doi: 10.1128/jvi.00205-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00205-15</ArticleId><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M. H. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines. Expert Review of Vaccines. 2015;14(3):337&#x2013;340. doi: 10.1586/14760584.2015.993385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2015.993385</ArticleId><ArticleId IdType="pubmed">25536888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren P., Zou G., Bailly B., et al. The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection&#x2014;suramin inhibits EV71 infection in vitro and in vivo. Emerging Microbes and Infections. 2014;3(9):p. 62. doi: 10.1038/emi.2014.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.60</ArticleId><ArticleId IdType="pmc">PMC4185360</ArticleId><ArticleId IdType="pubmed">26038755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H., Zhang Z., Dai Y., Liu S., Fu E. Brequinar inhibits enterovirus replication by targeting biosynthesis pathway of pyrimidines. American Journal of Tourism Research. 2020;12(12):8247&#x2013;8255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7791496</ArticleId><ArticleId IdType="pubmed">33437396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.-h., Luo Y.-j., Wu X.-y., Si B.-y., Lin L., Zhu Q.-y. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virology Journal. 2010;7(1):p. 106. doi: 10.1186/1743-422x-7-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-7-106</ArticleId><ArticleId IdType="pmc">PMC2887433</ArticleId><ArticleId IdType="pubmed">20500892</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.-X., Zhao H., Cao R.-Y., et al. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Virology Journal. 2014;11(1):p. 79. doi: 10.1186/1743-422x-11-79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-11-79</ArticleId><ArticleId IdType="pmc">PMC4030048</ArticleId><ArticleId IdType="pubmed">24885030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Fan R., Sun S., et al. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice. Vaccine. 2015;33(48):6596&#x2013;6603. doi: 10.1016/j.vaccine.2015.10.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.104</ArticleId><ArticleId IdType="pubmed">26529072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.-Y., Yang Y.-T., Yu S.-L., et al. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. Journal of Virology. 2013;87(16):9064&#x2013;9076. doi: 10.1128/jvi.00573-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Lee H, Hafenstein S, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathogens. 2013;9(7) doi: 10.1371/journal.ppat.1003511.e1003511</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.-W., Wang Y.-F., Yu C.-K., Su I.-J., Wang J.-R. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422(1):132&#x2013;143. doi: 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcminn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in western Australia. Clinical Infectious Diseases. 2001;32(2):236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z., Qi Y., et al. Molecular determinants of enterovirus 71 viral entry. Journal of Biological Chemistry. 2012;287(9):6406&#x2013;6420. doi: 10.1074/jbc.m111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wu X., Huang K., et al. The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infectious Diseases. 2014;14(1):p. 243. doi: 10.1186/1471-2334-14-243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-243</ArticleId><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Fu C., Wu S., et al. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 2014;48(2):260&#x2013;272. doi: 10.1007/s11262-014-1035-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1035-2</ArticleId><ArticleId IdType="pubmed">24442718</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan D., van der Sanden S., Zeng H, et al. Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One. 2012;7(9) doi: 10.1371/journal.pone.0044386.e44386</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044386</ArticleId><ArticleId IdType="pmc">PMC3440427</ArticleId><ArticleId IdType="pubmed">22984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim X. F., Jia Q., Khong W. X, et al. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS One. 2012;7(1) doi: 10.1371/journal.pone.0029751.e29751</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029751</ArticleId><ArticleId IdType="pmc">PMC3261156</ArticleId><ArticleId IdType="pubmed">22279543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Huang X, et al. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One. 2013;8(2) doi: 10.1371/journal.pone.0057601.e57601</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057601</ArticleId><ArticleId IdType="pmc">PMC3579802</ArticleId><ArticleId IdType="pubmed">23451250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.-C., Chou A.-H., Lien S.-P., et al. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine. 2011;29(26):4362&#x2013;4372. doi: 10.1016/j.vaccine.2011.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., He D., Li Z., et al. Protection against lethal enterovirus 71 Challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics. 2014;4(5):498&#x2013;513. doi: 10.7150/thno.7457.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.7457</ArticleId><ArticleId IdType="pmc">PMC3964443</ArticleId><ArticleId IdType="pubmed">24669278</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Li C., He D., et al. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2013;31(2):425&#x2013;430. doi: 10.1016/j.vaccine.2012.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.10.032</ArticleId><ArticleId IdType="pubmed">23088887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T. K., Qiang J., Tao M., Chow V. T. K., Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved &#x201c;knob&#x201d; region of VP3 protein. PLoS Neglected Tropical Diseases. 2014;8(5):p. 2895. doi: 10.1371/journal.pntd.0002895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan G., Wang Y. P., Mao Q. Y., et al. Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virology Journal. 2012;9(1):p. 26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3292509</ArticleId><ArticleId IdType="pubmed">22264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T. K., Jia Q., Lim X., et al. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virology Journal. 2012;9(1):p. 55. doi: 10.1186/1743-422x-9-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-9-55</ArticleId><ArticleId IdType="pmc">PMC3307493</ArticleId><ArticleId IdType="pubmed">22361222</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M. L., Chiang P. S., Chia M. Y, et al. Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLoS Neglected Tropical Diseases. 2013;7(2) doi: 10.1371/journal.pntd.0002067.e2067</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002067</ArticleId><ArticleId IdType="pmc">PMC3573098</ArticleId><ArticleId IdType="pubmed">23459633</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S., Tan X., Sun X., et al. VP2 dominated CD4+T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population. The Journal of Immunology. 2013;191(4):1637&#x2013;1647. doi: 10.4049/jimmunol.1301439.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301439</ArticleId><ArticleId IdType="pubmed">23863902</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Takebe Y., Wakita T., Shimizu H. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. Journal of General Virology. 2010;91(11):2734&#x2013;2744. doi: 10.1099/vir.0.023374-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.023374-0</ArticleId><ArticleId IdType="pubmed">20660150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Z., Wang B., Zhang X., et al. Crystal structure of 2A proteinase from hand, foot and mouth disease virus. Journal of Molecular Biology. 2013;425(22):4530&#x2013;4543. doi: 10.1016/j.jmb.2013.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.08.016</ArticleId><ArticleId IdType="pubmed">23973886</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell&#xf3; A., Alvarez E., Carrasco L. The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases. Journal of Biomedicine &amp; Biotechnology. 2011;2011 doi: 10.1155/2011/369648.369648</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/369648</ArticleId><ArticleId IdType="pmc">PMC3085340</ArticleId><ArticleId IdType="pubmed">21541224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.-L., Kung S.-H., Hsu Y.-Y., Liu W.-T. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. Journal of General Virology. 2002;83(6):1367&#x2013;1376. doi: 10.1099/0022-1317-83-6-1367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-6-1367</ArticleId><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C.-H., Li H.-C., Jiang J.-G., et al. Enterovirus type 71 2A protease functions as a transcriptional activator in yeast. Journal of Biomedical Science. 2010;17(1):p. 65. doi: 10.1186/1423-0127-17-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-17-65</ArticleId><ArticleId IdType="pmc">PMC2923119</ArticleId><ArticleId IdType="pubmed">20682079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H.-L., Si L.-Y., Yuan X.-J., et al. Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes. Virology Journal. 2013;10(1):p. 115. doi: 10.1186/1743-422x-10-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-10-115</ArticleId><ArticleId IdType="pmc">PMC3669102</ArticleId><ArticleId IdType="pubmed">23577963</ArticleId></ArticleIdList></Reference><Reference><Citation>Towner J. S., Ho T. V., Semler B. L. Determinants of membrane association for poliovirus protein 3AB. Journal of Biological Chemistry. 1996;271(43):26810&#x2013;26818. doi: 10.1074/jbc.271.43.26810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.43.26810</ArticleId><ArticleId IdType="pubmed">8900162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Yuan S., Zhang C., et al. Discovery of itraconazole with broad-SpectrumIn VitroAntienterovirus activity that targets nonstructural protein 3A. Antimicrobial Agents and Chemotherapy. 2015;59(5):2654&#x2013;2665. doi: 10.1128/aac.05108-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.05108-14</ArticleId><ArticleId IdType="pmc">PMC4394834</ArticleId><ArticleId IdType="pubmed">25691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. Journal of Virology. 2010;84(16):8051&#x2013;8061. doi: 10.1128/jvi.02491-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. Journal of Virology. 2012;87(3):1690&#x2013;1698. doi: 10.1128/jvi.01855-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-C., Chang L.-Y., Wang Y.-W., et al. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. Journal of Biological Chemistry. 2011;286(36):31373&#x2013;31384. doi: 10.1074/jbc.m111.254896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m111.254896</ArticleId><ArticleId IdType="pmc">PMC3173077</ArticleId><ArticleId IdType="pubmed">21784861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung Y. H., Huang S. W., Kuo P. H., et al. Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology. 2009;396(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19906393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Wang Y., Shan C., et al. Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. Journal of Virology. 2012;86(24):13662&#x2013;13671. doi: 10.1128/jvi.01712-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01712-12</ArticleId><ArticleId IdType="pmc">PMC3503026</ArticleId><ArticleId IdType="pubmed">23055549</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zheng Z., Shu B., et al. SUMO modification stabilizes enterovirus 71 polymerase 3D to facilitate viral replication. Journal of Virology. 2016;90(23):10472&#x2013;10485. doi: 10.1128/jvi.01756-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.-C., Chang H.-Y., Lin P.-F., et al. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrobial Agents and Chemotherapy. 2009;53(7):2740&#x2013;2747. doi: 10.1128/aac.00101-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.-L., Shih S.-R. Strategies to develop antivirals against enterovirus 71. Virology Journal. 2013;10(1):p. 28. doi: 10.1186/1743-422x-10-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-10-28</ArticleId><ArticleId IdType="pmc">PMC3614426</ArticleId><ArticleId IdType="pubmed">23339605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrerorta C., Arias A., Escarm&#xed;s C., Verdaguer N. A comparison of viral RNA-dependent RNA polymerases. Current Opinion in Structural Biology. 2006;16(1):27&#x2013;34. doi: 10.1016/j.sbi.2005.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2005.12.002</ArticleId><ArticleId IdType="pubmed">16364629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>